Crown antibodies pass additional stringent quality requirements, including extended control sets, uniform results against multiple biologically relevant cell lines and tissues, and function in multiple applications.
Researchers worldwide depend on Abcepta FLcDNA clones to accelerate their research. Expression-ready clones are convenient solution that decreases the time required to start an experiment and increases the chances of success.
Abcepta develops 1000+ new products per year. We provide tools for path-breaking research by developing antibodies that detect a comprehensive library of novel and established targets.